DE69433970D1 - Zelleinkapselungsvorrichtung - Google Patents

Zelleinkapselungsvorrichtung

Info

Publication number
DE69433970D1
DE69433970D1 DE69433970T DE69433970T DE69433970D1 DE 69433970 D1 DE69433970 D1 DE 69433970D1 DE 69433970 T DE69433970 T DE 69433970T DE 69433970 T DE69433970 T DE 69433970T DE 69433970 D1 DE69433970 D1 DE 69433970D1
Authority
DE
Germany
Prior art keywords
permeable membrane
core
devices
cells
zone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69433970T
Other languages
English (en)
Other versions
DE69433970T2 (de
Inventor
Mark D Butler
Stanley L Mish
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
WL Gore and Associates Inc
Original Assignee
WL Gore and Associates Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by WL Gore and Associates Inc filed Critical WL Gore and Associates Inc
Application granted granted Critical
Publication of DE69433970D1 publication Critical patent/DE69433970D1/de
Publication of DE69433970T2 publication Critical patent/DE69433970T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0085—Brain, e.g. brain implants; Spinal cord

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Dermatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Encapsulation Of And Coatings For Semiconductor Or Solid State Devices (AREA)
  • Optical Measuring Cells (AREA)
  • Transplanting Machines (AREA)
  • Physical Deposition Of Substances That Are Components Of Semiconductor Devices (AREA)
DE69433970T 1993-08-10 1994-06-24 Zelleinkapselungsvorrichtung Expired - Lifetime DE69433970T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10501193A 1993-08-10 1993-08-10
US105011 1993-08-10

Publications (2)

Publication Number Publication Date
DE69433970D1 true DE69433970D1 (de) 2004-09-30
DE69433970T2 DE69433970T2 (de) 2005-08-11

Family

ID=22303587

Family Applications (3)

Application Number Title Priority Date Filing Date
DE0938893T Pending DE938893T1 (de) 1993-08-10 1994-06-24 Zelleinkapselungsvorrichtung
DE69420024T Expired - Lifetime DE69420024T2 (de) 1993-08-10 1994-06-24 Zelleinkapselungsvorrichtung
DE69433970T Expired - Lifetime DE69433970T2 (de) 1993-08-10 1994-06-24 Zelleinkapselungsvorrichtung

Family Applications Before (2)

Application Number Title Priority Date Filing Date
DE0938893T Pending DE938893T1 (de) 1993-08-10 1994-06-24 Zelleinkapselungsvorrichtung
DE69420024T Expired - Lifetime DE69420024T2 (de) 1993-08-10 1994-06-24 Zelleinkapselungsvorrichtung

Country Status (9)

Country Link
US (2) US5980889A (de)
EP (2) EP0938893B1 (de)
AT (2) ATE183078T1 (de)
AU (1) AU678843B2 (de)
CA (1) CA2147626C (de)
DE (3) DE938893T1 (de)
DK (1) DK0663817T3 (de)
ES (1) ES2138665T3 (de)
WO (1) WO1995004521A1 (de)

Families Citing this family (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE183078T1 (de) * 1993-08-10 1999-08-15 Gore & Ass Zelleinkapselungsvorrichtung
US6187757B1 (en) 1995-06-07 2001-02-13 Ariad Pharmaceuticals, Inc. Regulation of biological events using novel compounds
WO1997010807A1 (en) * 1995-09-22 1997-03-27 Gore Hybrid Technologies, Inc. Improved cell encapsulation device
US5855613A (en) 1995-10-13 1999-01-05 Islet Sheet Medical, Inc. Retrievable bioartificial implants having dimensions allowing rapid diffusion of oxygen and rapid biological response to physiological change
US5952226A (en) * 1996-11-05 1999-09-14 Modex Therapeutiques Hypoxia responsive EPO producing cells
US6306491B1 (en) * 1996-12-20 2001-10-23 Gore Enterprise Holdings, Inc. Respiratory aids
WO1999005502A2 (en) * 1997-07-22 1999-02-04 The General Hospital Corporation Modulation of multicellular aggregates by solid stress
US6287558B1 (en) * 1997-08-01 2001-09-11 Biohybrio Technologies Llc Devices containing cells or tissue and an agent that inhibits damage by a host cell molecule
US6984635B1 (en) 1998-02-13 2006-01-10 Board Of Trustees Of The Leland Stanford Jr. University Dimerizing agents, their production and use
US6303136B1 (en) * 1998-04-13 2001-10-16 Neurotech S.A. Cells or tissue attached to a non-degradable filamentous matrix encapsulated by a semi-permeable membrane
US20020095157A1 (en) 1999-07-23 2002-07-18 Bowman Steven M. Graft fixation device combination
US6179840B1 (en) 1999-07-23 2001-01-30 Ethicon, Inc. Graft fixation device and method
AU2001233168A1 (en) * 2000-01-31 2001-08-07 Children's Medical Center Corporation Neural regeneration conduit
US20020127265A1 (en) * 2000-12-21 2002-09-12 Bowman Steven M. Use of reinforced foam implants with enhanced integrity for soft tissue repair and regeneration
CA2365376C (en) * 2000-12-21 2006-03-28 Ethicon, Inc. Use of reinforced foam implants with enhanced integrity for soft tissue repair and regeneration
US6599323B2 (en) * 2000-12-21 2003-07-29 Ethicon, Inc. Reinforced tissue implants and methods of manufacture and use
US6852330B2 (en) * 2000-12-21 2005-02-08 Depuy Mitek, Inc. Reinforced foam implants with enhanced integrity for soft tissue repair and regeneration
CZ298160B6 (cs) * 2001-01-18 2007-07-11 Prístroj pro vyvolání imunitní odezvy pri lécbe rakoviny
US20040191246A1 (en) 2003-02-26 2004-09-30 Connelly Patrick R. Process for in vivo treatment of specific biological targets in bodily fluid
AU2002310361A1 (en) * 2001-06-08 2002-12-23 Boehringer Ingelheim Pharmaceuticals, Inc. Methods for improving cell line activity in immunoisolation devices
AU2002323217B2 (en) 2001-08-15 2008-04-10 Brown University Research Foundation Treatment of muscular dystrophies and related disorders
US20040005298A1 (en) 2002-02-08 2004-01-08 Xcyte Therapies, Inc. Compositions and methods for restoring immune responsiveness in patients with immunological defects
US20030170278A1 (en) * 2002-03-11 2003-09-11 Wolf David E. Microreactor and method of determining a microreactor suitable for a predetermined mammal
JP2006506987A (ja) 2002-06-28 2006-03-02 エクサイト セラピーズ インコーポレーティッド 自己免疫および臓器または造血幹細胞移植に関連する免疫学的欠損を有する患者における免疫レパートリー回復のための組成物および方法
US7824701B2 (en) 2002-10-18 2010-11-02 Ethicon, Inc. Biocompatible scaffold for ligament or tendon repair
US20040078090A1 (en) 2002-10-18 2004-04-22 Francois Binette Biocompatible scaffolds with tissue fragments
US8197837B2 (en) 2003-03-07 2012-06-12 Depuy Mitek, Inc. Method of preparation of bioabsorbable porous reinforced tissue implants and implants thereof
MXPA05012080A (es) * 2003-05-08 2006-02-22 Xcyte Therapies Inc Generacion y aislamiento de celulas t especificas al antigeno.
US8226715B2 (en) 2003-06-30 2012-07-24 Depuy Mitek, Inc. Scaffold for connective tissue repair
US10583220B2 (en) 2003-08-11 2020-03-10 DePuy Synthes Products, Inc. Method and apparatus for resurfacing an articular surface
GB2407394A (en) 2003-10-23 2005-04-27 Dow Corning Ltd Optical waveguide with two differently dimensioned waveguiding layers on substrate
US7316822B2 (en) 2003-11-26 2008-01-08 Ethicon, Inc. Conformable tissue repair implant capable of injection delivery
US7901461B2 (en) 2003-12-05 2011-03-08 Ethicon, Inc. Viable tissue repair implants and methods of use
US11395865B2 (en) 2004-02-09 2022-07-26 DePuy Synthes Products, Inc. Scaffolds with viable tissue
US8137686B2 (en) 2004-04-20 2012-03-20 Depuy Mitek, Inc. Nonwoven tissue scaffold
US8221780B2 (en) 2004-04-20 2012-07-17 Depuy Mitek, Inc. Nonwoven tissue scaffold
US8657881B2 (en) 2004-04-20 2014-02-25 Depuy Mitek, Llc Meniscal repair scaffold
US20060257368A1 (en) * 2005-05-03 2006-11-16 Clemson University Devices and methods for improved viability of cells
US20090196854A1 (en) * 2008-02-04 2009-08-06 Kytos Biosystems S.A. Methods and compositions for use of crl 5803 cells for expression of biotherapeutics and encapsulated cell-based delivery
US20100080784A1 (en) * 2008-09-12 2010-04-01 Torrey Pines Institute For Molecular Studies Methods for treating cachexia and lymphopenia
WO2010083841A2 (en) 2009-01-23 2010-07-29 Nsgene A/S Improved cell lines and their use in encapsulated cell biodelivery
US9475709B2 (en) 2010-08-25 2016-10-25 Lockheed Martin Corporation Perforated graphene deionization or desalination
EP2621403B1 (de) * 2010-09-27 2015-03-18 NsGene A/S Implantierbare zellenvorrichtung mit stützendem und radialem diffusem gerüst
EP3026432A3 (de) 2010-12-27 2016-07-27 Brown University Verfahren zur vorhersage der patientenreaktion auf eine behandlung mit biglycan
JP2014525338A (ja) * 2011-09-06 2014-09-29 ステム セル サージカル リミテッド ライアビリティ カンパニー 手術用縫合糸ならびにその作製および使用の方法
WO2013078230A1 (en) 2011-11-23 2013-05-30 The Trustees Of The University Of Pennsylvania Use of pdl1 expressing cells to convert t cells into regulatory t cells
US9610546B2 (en) 2014-03-12 2017-04-04 Lockheed Martin Corporation Separation membranes formed from perforated graphene and methods for use thereof
US10653824B2 (en) 2012-05-25 2020-05-19 Lockheed Martin Corporation Two-dimensional materials and uses thereof
US9744617B2 (en) 2014-01-31 2017-08-29 Lockheed Martin Corporation Methods for perforating multi-layer graphene through ion bombardment
US10980919B2 (en) 2016-04-14 2021-04-20 Lockheed Martin Corporation Methods for in vivo and in vitro use of graphene and other two-dimensional materials
US10203295B2 (en) 2016-04-14 2019-02-12 Lockheed Martin Corporation Methods for in situ monitoring and control of defect formation or healing
US10376845B2 (en) 2016-04-14 2019-08-13 Lockheed Martin Corporation Membranes with tunable selectivity
US9834809B2 (en) 2014-02-28 2017-12-05 Lockheed Martin Corporation Syringe for obtaining nano-sized materials for selective assays and related methods of use
USD720469S1 (en) 2013-03-07 2014-12-30 Viacyte, Inc. Cell encapsulation device
US9592475B2 (en) 2013-03-12 2017-03-14 Lockheed Martin Corporation Method for forming perforated graphene with uniform aperture size
ES2786253T3 (es) 2013-03-14 2020-10-09 Immusoft Corp Métodos para la diferenciación y transducción in vitro de células b de memoria con vectores virales pseudotipados vsv-g
US9572918B2 (en) 2013-06-21 2017-02-21 Lockheed Martin Corporation Graphene-based filter for isolating a substance from blood
CN106029596A (zh) 2014-01-31 2016-10-12 洛克希德马丁公司 采用多孔非牺牲性支撑层的二维材料形成复合结构的方法
EP3100297A4 (de) 2014-01-31 2017-12-13 Lockheed Martin Corporation Perforierung von zweidimensionalen materialien mit einem breiten ionenfeld
EP3116625A4 (de) 2014-03-12 2017-12-20 Lockheed Martin Corporation Trennmembranen aus perforiertem graphen
EP3188823A4 (de) 2014-09-02 2018-04-25 Lockheed Martin Corporation Hämodialyse- und hämofiltrationsmembranen basierend auf einem zweidimensionalen membranmaterial und verfahren zur verwendung davon
AU2015339744B2 (en) 2014-10-31 2021-03-25 The Trustees Of The University Of Pennsylvania Altering gene expression in CART cells and uses thereof
US11471487B2 (en) 2014-10-31 2022-10-18 The Trustees Of The University Of Pennsylvania Compositions and methods of stimulating and expanding T cells
CA2971430A1 (en) 2014-12-19 2016-06-23 Immusoft Corporation B cells for in vivo delivery of therapeutic agents
US10828353B2 (en) 2015-01-31 2020-11-10 The Trustees Of The University Of Pennsylvania Compositions and methods for T cell delivery of therapeutic molecules
AU2016220324B2 (en) 2015-02-16 2020-07-02 The Trustees Of The University Of Pennsylvania A fully-human T cell receptor specific for the 369-377 epitope derived from the HER2/Neu (ERBB2) receptor protein
CA2994549A1 (en) 2015-08-05 2017-02-09 Lockheed Martin Corporation Perforatable sheets of graphene-based material
WO2017023377A1 (en) 2015-08-06 2017-02-09 Lockheed Martin Corporation Nanoparticle modification and perforation of graphene
US11110197B2 (en) * 2016-02-24 2021-09-07 Georgia Tech Research Corporation Surgical suture materials with porous sheaths for drug delivery
SG11201809016QA (en) 2016-04-14 2018-11-29 Lockheed Corp Selective interfacial mitigation of graphene defects
JP2019517909A (ja) 2016-04-14 2019-06-27 ロッキード・マーチン・コーポレーション 流路を有する二次元膜構造体
KR20190019907A (ko) 2016-04-14 2019-02-27 록히드 마틴 코포레이션 자유-플로팅 방법을 사용한 대규모 이송을 위한 그래핀 시트 취급 방법
JP7054523B2 (ja) * 2016-06-28 2022-04-14 国立研究開発法人農業・食品産業技術総合研究機構 細胞封入用デバイス及びその使用
CA3042866A1 (en) 2016-11-03 2018-05-11 Klearchos K. Papas Encapsulation device systems with oxygen sensors with or without exogenous oxygen delivery
SG10202104564SA (en) 2016-11-03 2021-06-29 Univ Arizona Methods and systems for real-time assessment of cells in encapsulation devices pre-and post-transplantation
US11707611B2 (en) 2016-11-08 2023-07-25 W. L. Gore & Associates, Inc. Implantable apparatus for retention of biological moieties
US11052230B2 (en) 2016-11-08 2021-07-06 W. L. Gore & Associates, Inc. Implantable encapsulation devices
JP7088564B2 (ja) 2016-11-10 2022-06-21 ヴィアサイト，インコーポレイテッド 細胞送達装置におけるｐｄｘ１膵臓内胚葉細胞及びその方法
RU2020133851A (ru) 2018-03-16 2022-04-19 Иммьюсофт Корпорейшн B-клетки, генетически модифицированные для секреции фоллистатина, и способы их применения для лечения связанных с фоллистатином заболеваний, состояний, нарушений и для увеличения роста и силы мышц
DE202019005887U1 (de) 2018-07-03 2023-06-14 Marengo Therapeutics, Inc. Anti-TCR-Antikörpermoleküle und Verwendungen davon
AU2019346547A1 (en) * 2018-09-24 2021-04-29 Procyon Technologies Llc Methods and systems for implantable medical devices and vascularization membranes

Family Cites Families (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3993072A (en) * 1974-08-28 1976-11-23 Alza Corporation Microporous drug delivery device
CA1085104A (en) * 1977-03-21 1980-09-09 Anthony M. Sun Artificial endocrine pancreas
US4743545A (en) * 1984-08-09 1988-05-10 Torobin Leonard B Hollow porous microspheres containing biocatalyst
US4409331A (en) * 1979-03-28 1983-10-11 Damon Corporation Preparation of substances with encapsulated cells
US4391909A (en) * 1979-03-28 1983-07-05 Damon Corporation Microcapsules containing viable tissue cells
US4298002A (en) * 1979-09-10 1981-11-03 National Patent Development Corporation Porous hydrophilic materials, chambers therefrom, and devices comprising such chambers and biologically active tissue and methods of preparation
US4420589A (en) * 1980-07-07 1983-12-13 Stoy Vladimir A Polymer composition including polyacrylonitrile polymers and process for preparing same
US4353888A (en) * 1980-12-23 1982-10-12 Sefton Michael V Encapsulation of live animal cells
US4495288A (en) * 1981-03-13 1985-01-22 Damon Biotech, Inc. Method of culturing anchorage dependent cells
US4378016A (en) * 1981-07-15 1983-03-29 Biotek, Inc. Artificial endocrine gland containing hormone-producing cells
US4505266A (en) * 1981-10-26 1985-03-19 Massachusetts Institute Of Technology Method of using a fibrous lattice
EP0120061A4 (de) * 1982-09-29 1986-08-21 Theodore E Spielberg Eingekapselte lebende genetisch programmierte organismen die arzneimittel erzeugen.
CA1196862A (en) * 1983-06-01 1985-11-19 Anthony M.F. Sun Microencapsulation of living tissue and cells
US4806355A (en) * 1983-06-06 1989-02-21 Connaught Laboratories Limited Microencapsulation of living tissue and cells
US4631188A (en) * 1983-08-31 1986-12-23 S.K.Y. Polymers, Ltd. (Kingston Technologies) Injectable physiologically-acceptable polymeric composition
US4803168A (en) * 1983-09-01 1989-02-07 Damon Biotech, Inc. Microencapsulation with polymers
AU3542684A (en) * 1983-11-15 1985-05-23 Johnson & Johnson Corporation Glycemia regulating implant
US4663286A (en) * 1984-02-13 1987-05-05 Damon Biotech, Inc. Encapsulation of materials
US4686098A (en) * 1984-05-14 1987-08-11 Merck & Co., Inc. Encapsulated mouse cells transformed with avian retrovirus-bovine growth hormone DNA, and a method of administering BGH in vivo
CA1215922A (en) * 1984-05-25 1986-12-30 Connaught Laboratories Limited Microencapsulation of living tissue and cells
US4722898A (en) * 1985-04-29 1988-02-02 Minnesota Mining And Manufacturing Company Immobilization of biological cells in polytetrafluoroethylene matrix
US4997443A (en) * 1985-08-26 1991-03-05 Hana Biologics, Inc. Transplantable artificial tissue and process
US4902295A (en) * 1985-08-26 1990-02-20 Hana Biologics, Inc. Transplantable artificial tissue
AU589438B2 (en) * 1985-08-26 1989-10-12 Hana Biologics, Inc. Transplantable artificial tissue and process
US5030225A (en) * 1987-03-13 1991-07-09 Brown University Research Foundation Electrically-charged nerve guidance channels
US5218039A (en) * 1987-04-28 1993-06-08 Kingston Technologies, Inc. Pan emulsion
US4911717A (en) * 1987-06-18 1990-03-27 Gaskill Iii Harold V Intravasular artificial organ
US4942129A (en) * 1987-07-28 1990-07-17 Queen's University At Kingston Multiple membrane microencapsulation
US5283187A (en) * 1987-11-17 1994-02-01 Brown University Research Foundation Cell culture-containing tubular capsule produced by co-extrusion
US5106627A (en) * 1987-11-17 1992-04-21 Brown University Research Foundation Neurological therapy devices
US5418154A (en) * 1987-11-17 1995-05-23 Brown University Research Foundation Method of preparing elongated seamless capsules containing biological material
US5158881A (en) * 1987-11-17 1992-10-27 Brown University Research Foundation Method and system for encapsulating cells in a tubular extrudate in separate cell compartments
US5182111A (en) * 1987-11-17 1993-01-26 Boston University Research Foundation In vivo delivery of active factors by co-cultured cell implants
US4892538A (en) * 1987-11-17 1990-01-09 Brown University Research Foundation In vivo delivery of neurotransmitters by implanted, encapsulated cells
JPH037751A (ja) * 1988-03-04 1991-01-14 Kingston Technol Ltd Partnership 新規ポリアクリロニトリル組成物およびその製造方法
US5081035A (en) * 1988-04-18 1992-01-14 The University Of Michigan Bioreactor system
US4941812A (en) * 1988-05-10 1990-07-17 E. I. Du Pont De Nemours And Company Spinneret for production of a hollow filament within a hollow filament composite fiber having spacing means
FR2634382B1 (fr) * 1988-07-21 1990-10-26 Applic Techn Photoniques Pancreas artificiel
WO1990001498A1 (en) * 1988-08-12 1990-02-22 Cell Biotech, Inc. Process for purification of islet cells; monoclonal antibodies directed to islet and acinar cells; and process for making and using same
CA1323959C (en) * 1988-09-16 1993-11-09 Andreas F. Von Recum Soft tissue implant with micron-scale surface texture to optimize anchorage
US5011486A (en) * 1988-11-18 1991-04-30 Brown University Research Foundation Composite nerve guidance channels
US5017490A (en) * 1989-03-10 1991-05-21 Baxter International Inc. Method for in vitro reproduction and growth of cells in culture medium
AU636346B2 (en) * 1989-04-25 1993-04-29 Children's Hospital Method for implanting large volumes of cells on polymeric matrices
DK0478671T3 (da) * 1989-06-21 1993-10-18 Univ Brown Res Found Neurologisk terapeutisk anordning
WO1991000119A1 (en) * 1989-06-30 1991-01-10 Baxter International Inc. Implantable device
US5002661A (en) * 1989-08-25 1991-03-26 W. R. Grace & Co.-Conn. Artificial pancreatic perfusion device
US5116493A (en) * 1989-08-25 1992-05-26 W. R. Grace & Co.-Conn. Artificial pancreatic perfusion device with reseedable matrix
US5116494A (en) * 1989-08-25 1992-05-26 W. R. Grace & Co.-Conn. Artificial pancreatic perfusion device with temperature sensitive matrix
US5100392A (en) * 1989-12-08 1992-03-31 Biosynthesis, Inc. Implantable device for administration of drugs or other liquid solutions
WO1991010470A1 (en) * 1990-01-08 1991-07-25 Brown University Research Foundation Devices and methods for enhanced delivery of active factors
US4969705A (en) * 1990-01-19 1990-11-13 Kingston Technologies, L.P. Memory polymer multiple cavity fiber splicer
US5084350A (en) * 1990-02-16 1992-01-28 The Royal Institution For The Advance Of Learning (Mcgill University) Method for encapsulating biologically active material including cells
US5256418A (en) * 1990-04-06 1993-10-26 Organogenesis, Inc. Collagen constructs
US5344454A (en) * 1991-07-24 1994-09-06 Baxter International Inc. Closed porous chambers for implanting tissue in a host
US5314471A (en) * 1991-07-24 1994-05-24 Baxter International Inc. Tissue inplant systems and methods for sustaining viable high cell densities within a host
KR0169495B1 (ko) * 1990-10-31 1999-01-15 쥐. 마샬 애비 폐쇄 혈관신생 이식 물질
DE4108772A1 (de) * 1991-03-18 1992-09-24 Inst Textil & Faserforschung Implantierbares biohybrides organ
EP0585368B1 (de) * 1991-04-25 1997-08-06 Brown University Research Foundation Implantierbare, biokompatible immunisolator-trägersubstanz zum abgeben ausgesuchter, therapeutischer produkte
US5453278A (en) * 1991-07-24 1995-09-26 Baxter International Inc. Laminated barriers for tissue implants
US5116753A (en) * 1991-07-30 1992-05-26 The Salk Institute For Biological Studies Maintenance of pancreatic islets
DE69219613T2 (de) * 1991-10-30 1997-11-27 Childrens Medical Center Vorvaskularisierte polymerimplantate für organtransplantation
ATE208169T1 (de) * 1992-04-01 2001-11-15 Baxter Int Systeme zum einpflanzen von gefässbildendem gewebe
AU4114993A (en) * 1992-04-24 1993-11-29 Polymer Technology Group, Inc., The Biocompatible, therapeutic, implantable device
CA2134088A1 (en) * 1992-04-24 1993-11-11 Robert S. Ward Method of culturing viable cells and method of regulating the level of a compound in a body fluid
ATE218614T1 (de) * 1992-09-28 2002-06-15 Univ Brown Res Found Chitozanmatrizes für eingekapselte zellen
ATE183078T1 (de) * 1993-08-10 1999-08-15 Gore & Ass Zelleinkapselungsvorrichtung
JPH08507949A (ja) * 1994-01-11 1996-08-27 バクスター、インターナショナル、インコーポレイテッド ポート付きの組織埋め込みシステム及びその使用方法

Also Published As

Publication number Publication date
ATE274340T1 (de) 2004-09-15
CA2147626A1 (en) 1995-02-16
EP0938893A1 (de) 1999-09-01
WO1995004521A1 (en) 1995-02-16
CA2147626C (en) 1998-04-21
US5980889A (en) 1999-11-09
US6426214B1 (en) 2002-07-30
ATE183078T1 (de) 1999-08-15
DE69433970T2 (de) 2005-08-11
ES2138665T3 (es) 2000-01-16
DE69420024T2 (de) 2000-02-24
DE69420024D1 (de) 1999-09-16
DK0663817T3 (da) 2000-03-13
AU7356394A (en) 1995-02-28
EP0663817A1 (de) 1995-07-26
EP0938893B1 (de) 2004-08-25
AU678843B2 (en) 1997-06-12
EP0663817B1 (de) 1999-08-11
DE938893T1 (de) 2000-03-09

Similar Documents

Publication Publication Date Title
DE69433970D1 (de) Zelleinkapselungsvorrichtung
ES2178654T3 (es) Capsulas biocompatibles inmonoaisladoras que contienen celulas geneticamente alteradas para el suministro de moleculas biologicamente activas.
AU2544201A (en) Implantable device
DK463586A (da) Fsh
FI930883A (fi) In vivo -dosering av aktiva faktorer med hjaelp av samodlade cellimplantat
KR960703343A (ko) 밀봉주입식 박막 캡슐장치 및 그 제조방법(method and apparatus for sealing implantable, membrane encapsulation devices)
EP0957888A4 (de) Lippenbehandlungsmittel enthaltend ein derivat lebender hefezellen
ATE350068T1 (de) Terminal-sterilisierte osteogene vorrichtungen und ihre herstellung
CA2346644A1 (en) Method for preventing xenograft transplant rejection using photodynamic therapy
PL298890A1 (en) Sulfonylobenzyl substituted benzo- and pyridopyridones, method of obtaining sames and therapeutic agents containing them
AU6389086A (en) A method for the treatment of atherosclerosis, thrombosis and peripheral vesseldisease
ATE410054T1 (de) Durch elektroporation vermittelter molekulartransfer in intakten pflanzen
NO975545L (no) Cellelinje som produserer analgetiske forbindelser for behandling av smerte
WO1998027966A3 (en) Encapsulated cells producing antibodies
DK273490A (da) Fremgangsmaade til udvinding af humant interleukin-4 fra bakterier
DE3483850D1 (de) Tablette mit kontrollierter freigabe.
NO170936C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive, substituerte vinylcefalosporiner
WO1990000314A3 (en) Method of activation of superconductors and devices produced thereby
SU1662315A1 (ru) Активный элемент для твердотельных лазеров из кристалла галлий-скандий-гадолиниевого граната
TR22871A (tr) Birden fazla aktif bilesen ihtiva eden piretroid terkipleri
Tyroler Selected Sources On Central America
JPS5367390A (en) Semiconductor laser device
MX9604832A (es) Un metodo para implantar celulas encapsuladas en un hospedero.
MD950100A (en) Substituted oximethers method of their preparation and application for pests and fungus control
HUT49470A (en) Insecticide with selectiv influence and process for production of the active substance

Legal Events

Date Code Title Description
8364 No opposition during term of opposition